Recent Posts
Archives
Learn more about HaemaLogix’s ground-breaking KappaMab technology
KappaMab is a monoclonal antibody developed by HaemaLogiX to treat blood cancers, with an initial focus on multiple myeloma.
IR Department acknowledge the Traditional Owners of the land on which it operates and pays respect to Elders past, present and emerging.
Subscribe
By subscribing you agree to with our Privacy Policy
IR Department
. All rights reserved.
- Site by 